Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

eLife, 2025
Causal associations between human plasma proteins and prostate cancer identified by proteome-wide Mendelian randomization

Chen L., Gu Y., Chen Y. et al.

Olink Explore 3072/384OncologyPathophysiologyPlasma

Nature Communications, 2025
Multivariate genome-wide analyses of insulin resistance unravel novel loci and therapeutic targets for cardiometabolic health

Ye C., Dou C., Liu D. et al.

Olink Explore 3072/384Metabolic DiseasesPathophysiologyPlasma

Human Molecular Genetics, 2025
Observational and Mendelian randomization studies of plasma sclerostin levels do not provide evidence of cardiovascular adverse effects of sclerostin inhibition

Thorolfsdottir R., Sveinbjornsson G., Hjorleifsson Eldjarn G. et al.

Olink Explore 3072/384CVDPathophysiologyPlasma

Allergy, 2025
Large‐Scale Blood Proteomic Analysis Across Different Inflammatory Skin Conditions Reveals Extensive Immune Dysregulation With Distinct Biomarker Profiles

Glickman J., David E., Shokrian N. et al.

Olink Explore 3072/384Immunological & Inflammatory DiseasesPathophysiologyPatient StratificationSerum

Pediatric Infectious Disease Journal, 2025
SARS-CoV-2 Infection Versus Vaccination During Pregnancy: Implications for Placental Antibody Transfer

Perez-Latorre L., Cohen S., Sánchez P. et al.

Olink Target 96Infectious DiseasesPathophysiologyCord Blood

eBioMedicine, 2025
Skeletal muscle-derived IL-33 mediates muscle-to-bone crosstalk and regulates bone metabolism via CD8+ T cell-secreted CCL5

Liu M., Han Y., Wang J. et al.

Olink Target 96OrthopedicsPathophysiologyPlasma

iScience, 2025
Targeted proteomics reveals immune protein patterns in serum from patients with calcific aortic stenosis

Mallia A., Binatti A., Sangiorgi D. et al.

Olink Target 96CVDPathophysiologyPatient StratificationSerum

Clinical Pharmacology & Therapeutics, 2025
Breaking Barriers: Characterization of the Intradermal Lipopolysaccharide Challenge as an In Vivo Model for Controlled Induction of Vascular Leakage in Healthy Volunteers

van Ruissen M., van Diemen M., Botros L. et al.

Olink Explore 3072/384Technical StudiesPathophysiologyBlister Fluid

Discover Oncology, 2025
Causal association between inflammatory markers and malignant neoplasms of bone and articular cartilage using Mendelian randomization

Liu C., Yu C., Wang W. et al.

Olink Target 96OncologyPathophysiologyPlasma

Scientific Reports, 2025
Comparison of three multiplex immunoassays for biomarker analysis in stratum corneum tape strips

Metwally N., de Boer F., Vreeken J. et al.

Olink Target 96Dermatological DiseasesTechnology EvaluationSkin Tape Strips

Scientific Reports, 2025
Sex- and strain-differential plasma proteomic signatures in C57BL/6 and BALB/c mice

Suh Y., Kim K.

Olink Target 96 MouseOlink Target 48 MouseWider Proteomics StudiesEpidemiologyMouse Plasma

Biomedicine & Pharmacotherapy, 2025
Apremilast attenuates hepatic steatosis and metabolic dysfunction in a murine model of MASLD: Implications for patients with Psoriatic disease

Ruiz-Ponce M., Rodriguez-Cuenca S., Martin-Salazar J. et al.

Olink Target 96 MouseMetabolic DiseasesHepatologyPathophysiologyMouse Tissue LysateMouse Serum

BMC Infectious Diseases, 2025
Identification of protein biomarkers to differentiate between gram-negative and gram-positive infections in adults suspected of sepsis

Irani Shemirani M., Pernestig A., Björkman J. et al.

Olink Target 96Infectious DiseasesPatient StratificationPlasma

Investigative Ophthalmology & Visual Science, 2025
Serum Biomarkers Linked to Disease Activity, Severity, and Methylprednisolone Response in Graves’ Orbitopathy: A Proteomic Study

Hӧtte G., Kolijn P., de Bie M. et al.

Olink Explore 3072/384OphthalmologyPatient StratificationSerum

Precision Clinical Medicine, 2025
Randomized Controlled Clinical Trial of Shenzhuo Formula in the Treatment of Macroalbuminuria in Diabetic Kidney Disease and Its Inflammation-Modulating Mechanisms

Anzhu W., Yishan H., Yu W. et al.

Olink Target 96Metabolic DiseasesNephrologyPathophysiologyPlasma

European Journal of Neurology, 2025
AXIN1, STAMBP, ST1A1, CDCP1, and SIRT2 Validated as Myasthenia Gravis Biomarkers: A Comparative Proteomic Study With MS, CIDP, and Controls

Bhandage A., Hoffmann S., Dusemund C. et al.

Olink Target 96Immunological & Inflammatory DiseasesPatient StratificationSerum

Clinica Chimica Acta, 2025
Olink proteomics profiling platform reveals myocardial metabolism-associated protein biomarkers in heart failure with preserved ejection fraction (HFpEF)

Chen X., Huang Y., Liu L. et al.

Olink Target 96CVDPathophysiologyPlasma

PM&R, 2025
Genetically predicted KIR2DS4 mediate the association between gut microbe K10 and osteoporosis fractures: A mediation Mendelian randomization study

Wang Q., Kuang Q., Chen C. et al.

Olink Explore 3072/384OrthopedicsPathophysiologyPlasma

Arthritis Research & Therapy, 2025
Inflammation-related proteomics of extracellular vesicles as novel biomarkers for systemic lupus erythematosus revealed by proximity extension assay

Zhan S., Wang Z., Xu Y. et al.

Olink Target 96Immunological & Inflammatory DiseasesPatient StratificationEV Lysate

Nutrition & Metabolism, 2025
Risk prediction of early-onset myocardial infarction using plasma proteomics, conventional risk factors, and polygenic risk score

Liu Z., Fang F., Qian Y. et al.

Olink Explore 3072/384CVDPatient StratificationPlasma

3635 publications